| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,286 |
4,335 |
$408K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,383 |
3,716 |
$216K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
809 |
650 |
$115K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,071 |
843 |
$82K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
927 |
693 |
$64K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
719 |
636 |
$55K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
515 |
429 |
$42K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
817 |
742 |
$19K |
| 96127 |
|
954 |
811 |
$17K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
49 |
37 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
830 |
691 |
$13K |
| 96160 |
|
801 |
609 |
$12K |
| 92551 |
|
753 |
618 |
$11K |
| 90686 |
|
957 |
824 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
273 |
179 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
201 |
166 |
$8K |
| 90698 |
|
437 |
313 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
389 |
335 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
262 |
176 |
$5K |
| 90671 |
|
231 |
149 |
$5K |
| 85018 |
|
1,822 |
1,479 |
$4K |
| 83655 |
|
288 |
234 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
81 |
61 |
$3K |
| D1206 |
Topical application of fluoride varnish |
127 |
111 |
$3K |
| 90674 |
|
195 |
168 |
$3K |
| 90670 |
|
240 |
200 |
$3K |
| 90680 |
|
184 |
119 |
$3K |
| 83718 |
|
291 |
230 |
$2K |
| 99173 |
|
288 |
229 |
$2K |
| 36416 |
|
477 |
400 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
88 |
74 |
$2K |
| 99174 |
|
184 |
143 |
$1K |
| 90661 |
|
77 |
76 |
$1K |
| 82465 |
|
284 |
230 |
$1K |
| 90633 |
|
81 |
49 |
$1K |
| 90651 |
|
100 |
60 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
14 |
$872.27 |
| 90700 |
|
68 |
54 |
$809.36 |
| 94760 |
|
197 |
184 |
$732.88 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
52 |
52 |
$616.88 |
| 90619 |
|
40 |
16 |
$614.45 |
| 90715 |
|
29 |
13 |
$434.79 |
| 90744 |
|
22 |
16 |
$367.62 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$307.80 |
| 90656 |
|
13 |
13 |
$217.23 |
| 81002 |
|
16 |
12 |
$41.60 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
12 |
12 |
$0.00 |